Efficacy and safety of immunotherapy combined with chemotherapy in patients with ES‐SCLC: A systematic review and network meta‐analysis of RCTs and RWSs

Abstract Objectives To evaluate the efficacy and safety of programmed cell death 1 (PD‐1)/programmed cell death ligand 1 (PD‐L1) inhibitors in the treatment of extensive‐stage small‐cell lung cancer (ES‐SCLC), we conducted a systematic review and meta‐analysis that included randomized controlled tri...

Full description

Saved in:
Bibliographic Details
Main Authors: Runting Kang, Junling Ma, Bin Ai, Juanjuan Liu, Zitong Zheng, Jiangyong Yu
Format: Article
Language:English
Published: Wiley 2024-11-01
Series:Thoracic Cancer
Subjects:
Online Access:https://doi.org/10.1111/1759-7714.15458
Tags: Add Tag
No Tags, Be the first to tag this record!